Bone Healing After Dental Extraction in Postmenopausal Osteoporotic Women Treated With Alendronate Per os Weekly
NCT01648686 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 66
Last updated 2025-09-05
Summary
The purpose of this study is to determine whether the oral alendronate treatment of post-menopausal osteoporosis could be a risk factor for jaw bone healing after dental extraction.
Conditions
- Alveolar Bone Healing After Dental Extraction
Interventions
- PROCEDURE
-
Dental extraction
3 dental radiographies realised immediately, then 30 days, then 90 days after dental extraction
Sponsors & Collaborators
-
URC-CIC Paris Descartes Necker Cochin
collaborator OTHER -
Assistance Publique - Hôpitaux de Paris
lead OTHER
Principal Investigators
-
Christian ROUX, MD, PhD · Hôpital Cochin
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- SCREENING
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 45 Years
- Max Age
- 70 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-09-19
- Primary Completion
- 2015-09-23
- Completion
- 2015-11-05
Countries
- France
Study Locations
More Related Trials
-
The Change of Bone Markers After Low Dose Alendronate in Postmenopausal Women With Bone Loss
NCT00460057 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Effervescent Alendronate on Bone Turnover
NCT05325515 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate and Compare Alendronate and Risedronate on Bone Mineral Density in Women With Postmenopausal Osteoporosis (MK-0217-211)
NCT00092014 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Alendronate 70mg Formulation on Bone Turnover Markers and Patient Reported Outcomes
NCT03435094 ·Status: UNKNOWN
-
Drug Holidays in the Treatment With Alendronate in Postmenopausal Women With Osteoporosis
NCT00936260 ·Status: COMPLETED ·Phase: NA
-
A Study and 12 Month Extension to Evaluate Two Investigational Drugs in Postmenopausal Women With Osteoporosis (MK-0217-907)
NCT00092040 ·Status: COMPLETED ·Phase: PHASE3
-
A Comparison Study With Alendronate and Raloxifene in Postmenopausal Women With Osteoporosis (0217-189)
NCT00389740 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacokinetics of a Single 14C-labeled Dose of Risedronate or Alendronate Followed by Once-a-week Unlabeled Oral Dose
NCT00577850 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety and Tolerability of MK0217 in Women (0217-219)
NCT00092027 ·Status: COMPLETED ·Phase: PHASE3
-
Safety/Efficacy of Zoledronic Acid and Alendronate on Bone Metabolism in Postmenopausal Women With Osteoporosis
NCT00404820 ·Status: COMPLETED ·Phase: PHASE3
-
Denosumab vs Alendronate After Vertebroplasty
NCT05662358 ·Status: UNKNOWN ·Phase: NA
-
A Research Study to Evaluate the Safety and Effectiveness of MK0217 to Prevent and Treat Bone Loss (0217-193)(COMPLETED)
NCT00480766 ·Status: COMPLETED ·Phase: PHASE3
-
Alendronate and/or Parathyroid Hormone for Osteoporosis
NCT00000400 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Safety and Efficacy of Denosumab and Actonel® in Post Menopausal Women Transitioned From Alendronate Therapy
NCT00919711 ·Status: COMPLETED ·Phase: PHASE3
-
4-Week Study to Assess the Effect of Alendronate and Vitamin D3 Once Weekly on Fractional Calcium Absorption in Postmenopausal Osteoporotic Women (0217A-230)
NCT00641771 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Actonel on Periodontal Health of Postmenopausal Women
NCT00594334 ·Status: WITHDRAWN ·Phase: PHASE4
-
Low-Dose Hormone Replacement Therapy and Alendronate for Osteoporosis
NCT00000430 ·Status: TERMINATED ·Phase: PHASE3
-
A Study to Compare the Efficacy of Alendronate With and Without Calcium or Calcium Alone In the Treatment of Osteoporosis in Postmenopausal Women (0217-088)(COMPLETED)
NCT00398606 ·Status: COMPLETED ·Phase: PHASE3
-
Twenty-Four Month Extension Study of BA058-05-003 (Abaloparatide) in Participants With Osteoporosis
NCT01657162 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Actonel® After Denosumab Discontinuation in Postmenopausal Osteoporosis Women
NCT05630768 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Safety, Tolerability, and Efficacy of an Investigational Drug and Dietary Supplement in Men and Postmenopausal Women With Osteoporosis (0217A-227)
NCT00092066 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Raloxifene Plus Cholecalciferol and Cholecalciferol Alone on the Bone Mineral Density in Postmenopausal Women With Osteopenia
NCT05386784 ·Status: COMPLETED ·Phase: PHASE4
-
Osteoporosis Treatment in Post-menopausal Women
NCT03006003 ·Status: UNKNOWN ·Phase: PHASE4
-
The Effect of PTH(1-84) or Alendronate on Reduction of Back Pain in Postmenopausal Women With an Osteoporosis Related Vertebral Fracture(s) (FP-005-IM)
NCT00713258 ·Status: TERMINATED ·Phase: PHASE4
-
Bone Effects of Teriparatide Following Alendronate
NCT00191893 ·Status: COMPLETED ·Phase: PHASE3